Invention Grant
- Patent Title: Substituted xanthine derivatives
-
Application No.: US15922265Application Date: 2018-03-15
-
Publication No.: US10335413B2Publication Date: 2019-07-02
- Inventor: Roger D. Tung , Julie F. Liu , Scott L. Harbeson
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Wei Song
- Main IPC: A61K31/522
- IPC: A61K31/522 ; C07D473/06

Abstract:
This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentoxifylline. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions for which pentoxifylline and related compounds are beneficial.
Public/Granted literature
- US20180333417A1 SUBSTITUTED XANTHINE DERIVATIVES Public/Granted day:2018-11-22
Information query
IPC分类: